Dr. Viral Jashvantbhai Patel

Dr. Viral Patel is a highly experienced Gynaecological Oncologist, Robotic Surgeon, and FACS-certified Cancer Surgeon, specialising in the comprehensive treatment of uterine, ovarian, and cervical cancers. With nearly a decade of exclusive focus on gynaecological oncology and over 1,500 successful cancer surgeries, Dr. Patel offers advanced robotic surgery, minimally invasive cancer surgery, cytoreductive surgery, HIPEC, Sentinel lymph node mapping technique, and PIPAC for complex and advanced-stage gynaecological cancers. His patient-centric approach focuses on early diagnosis, surgical precision, faster recovery, and long-term quality of life.

Dr. Patel is among the first formally trained and registered Gynaecological Oncologists in Gujarat and is a Fellow of the American College of Surgeons (FACS). Known for managing complex cases using minimally invasive techniques, he combines global cancer care standards with a compassionate approach to ensure women have access to advanced cancer treatment close to home.

• MBBS
• DNB – Obstetrics & Gynaecology
• M.Ch. – Gynaecological Oncology, Amrita Institute of Medical Sciences and Research Centre
• European Society of Gynaecological Oncology (ESGO) Certification
• FACS – Fellow, American College of Surgeons
• Stanford University Certified Course in Palliative Care
• Fellowship Training Certification Programme in Robotic Surgery with the Intuitive robotic surgical platform, Amrita Institute of Medical Sciences
• International Gynaecological Oncology Observership, Massachusetts General Hospital (MGH), USA
• ESGO Certification in Theoretical Examination

• Senior Consultant – Gynaecological Oncology & Robotic Oncosurgery, HCG Aastha Cancer Centre, HCG Hospitals, Ahmedabad
• Consultant – Gynaecological Oncology, Parul Sevashram Hospital
• Senior Registrar, Amrita Institute of Medical Sciences and Research Centre
• Resident Doctor, Aster MIMS, Calicut

• 2019 – Stanford University, USA – Certified Course in Palliative Care
• 2020 – Intuitive Surgical Fellowship Training Programme – Advanced Robotic Surgery Certification, Amrita Institute of Medical Sciences, India
• 2021 – Massachusetts General Hospital (MGH), USA – International Observership in Gynaecological Oncology
• 2022 – European Society of Gynaecological Oncology (ESGO) – Certification in Theoretical Examination
• 2024 – Fellow of the American College of Surgeons (FACS)
• 2024 – Economic Times Healthcare Awards- Oncologist of the Year (West)

• European Society of Gynaecological Oncology (ESGO)
• Association of Gynaecologic Oncologists of India (AGOI)
• Association of Gynaecological Robotic Surgeons
• Association of Minimal Access Surgeons of India (AMASI)
• Federation of Obstetric and Gynaecological Societies of India (FOGSI)
• Indian Medical Association (IMA)
• American College of Surgeons (ACS)
• Indian Society for Assisted Reproduction

• Robotic & Laparoscopic Gynaecologic Cancer Surgery
• Minimally invasive surgery for selected ovarian, uterine, cervical and other gynaecologic cancers, using robotic and laparoscopic techniques when appropriate.
• HIPEC for Advanced Ovarian Cancer
• Cytoreductive surgery with HIPEC for carefully selected patients with advanced ovarian cancer and peritoneal disease.
• PIPAC for Advanced Peritoneal Cancer
• Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for selected patients with advanced or recurrent cancers involving the peritoneum, when appropriate as part of an individualised treatment plan.
• Comprehensive Ovarian Cancer Cytoreductive Surgery
• Advanced surgery to remove visible cancer deposits in ovarian cancer, to achieve optimal cytoreduction whenever safely possible.
• Robotic Radical Hysterectomy
• Robotic radical hysterectomy for selected patients with early-stage cervical cancer when minimally invasive surgery is appropriate.
• Minimally Invasive Surgery for Uterine Cancer
• Robotic and laparoscopic surgery for selected patients with endometrial and other uterine cancers.
• Sentinel Lymph Node Mapping
• Sentinel lymph node mapping and biopsy to identify the first lymph nodes likely to contain cancer cells, helping assess lymph-node involvement while potentially reducing the need for more extensive lymph-node surgery in appropriately selected patients.
• Specialised Cervical Cancer Surgery
• Surgical management of selected cervical cancers, including radical surgery and fertility-sparing procedures when appropriate.
• Vulvar Cancer Surgery
• Specialised surgical treatment of vulvar cancer, including wide local excision and other cancer-directed procedures based on tumour location, size and stage.
• Fertility-Sparing Cancer Care
• Individualised treatment planning for selected young patients who wish to preserve fertility while maintaining appropriate cancer treatment.
• Expert Second Opinions & Complex Cancer Cases
• Specialist review of complex gynaecologic cancer cases, including diagnosis, staging, treatment options, surgical planning and second opinions.

1. Association of molecular subgroups with pathological parameters in endometrial carcinomas. Indian Journal of Cancer, April 2023.
2. A prospective observational study assessing the feasibility and factors affecting same-day discharge in patients undergoing robotic-assisted surgery for gynaecological cancers. Journal of Robotic Surgery, January 2022.
3. Impact of intraoperative tumour spillage in uterine leiomyosarcoma: A retrospective single-institutional analysis. Indian Journal of Surgical Oncology, August 2021.
4. A study on the detection rates and location of sentinel lymph nodes in patients with gynecologic cancers—the Journal of Obstetrics and Gynaecology of India, August 2021.
5. Modifications made for minimally invasive gynecologic oncology surgery during the COVID-19 pandemic period. The Journal of Obstetrics and Gynaecology of India, June 2021.
6. Ten-year survival outcome of breast cancer patients in India. Journal of Carcinogenesis, March 2021. DOI: 10.4103/jcar.JCar_26_20
7. Long-term survival outcome of advanced epithelial ovarian cancer: A single institutional study. Indian Journal of Cancer, October 2020. DOI: 10.4103/ijc.IJC_165_19
8. COVID-19 and impact on gynecologic oncology practice in India – results of a nationwide survey. Ecancer, 14:1067.
9. Ureteric mapping with indocyanine green (ICG): A new tool to prevent ureteral injury in complex gynaecological surgery. Journal of Endometriosis and Pelvic Pain Disorders, July 2020. DOI: 10.1177/2284026520934272
10. An analysis of operating time over the years for robotic-assisted surgery in gynaecology and gynecologic oncology. Journal of Robotic Surgery, May 2020. DOI: 10.1007/s11701-020-01094-3
11. Reducing the cost of robotic hysterectomy: Assessing the safety and efficacy of using ProGrasp forceps in lieu of a needle holder for vaginal cuff closure. Journal of Robotic Surgery, April 2020.
12. Long-term morbidity after endometrial cancer surgery: A comparison of open vs. robotic approach. Indian Journal of Surgical Oncology, June 2019; 10(2): 292–295. DOI: 10.1007/s13193-019-00906-9
13. Randomised controlled trial evaluating the impact of intravenous iron (ferric carboxymaltose) supplementation among epithelial ovarian cancer patients with anaemia. Indian Journal of Surgical Oncology, 2024.